Roscovitine blocks collecting duct cyst growth in Cep164-deficient kidneys.


Journal

Kidney international
ISSN: 1523-1755
Titre abrégé: Kidney Int
Pays: United States
ID NLM: 0323470

Informations de publication

Date de publication:
08 2019
Historique:
received: 13 12 2018
revised: 11 03 2019
accepted: 05 04 2019
pubmed: 30 6 2019
medline: 2 10 2020
entrez: 29 6 2019
Statut: ppublish

Résumé

Nephronophthisis is an autosomal recessive kidney disease with high genetic heterogeneity. Understanding the functions of the individual genes contributing to this disease is critical for delineating the pathomechanisms of this disorder. Here, we investigated kidney function of a novel gene associated with nephronophthisis, CEP164, coding a centriolar distal appendage protein, using a Cep164 knockout mouse model. Collecting duct-specific deletion of Cep164 abolished primary cilia from the collecting duct epithelium and led to rapid postnatal cyst growth in the kidneys. Cell cycle and biochemical studies revealed that tubular hyperproliferation is the primary mechanism that drives cystogenesis in the kidneys of these mice. Administration of roscovitine, a cell cycle inhibitor, blocked cyst growth in the cortical collecting ducts and preserved kidney parenchyma in Cep164 knockout mice. Thus, our findings provide evidence that therapeutic modulation of cell cycle activity can be an effective approach to prevent cyst progression in the kidney.

Identifiants

pubmed: 31248650
pii: S0085-2538(19)30472-7
doi: 10.1016/j.kint.2019.04.014
pmc: PMC6650321
mid: NIHMS1528880
pii:
doi:

Substances chimiques

Cep164 protein, mouse 0
Microtubule Proteins 0
Organoselenium Compounds 0
Protein Kinase Inhibitors 0
diselanylbis(1,3-dimethyl-1H-imidazol-3-ium) 0
Roscovitine 0ES1C2KQ94
Cyclin-Dependent Kinases EC 2.7.11.22

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

320-326

Subventions

Organisme : NIDDK NIH HHS
ID : P30 DK079307
Pays : United States
Organisme : NIDDK NIH HHS
ID : K99 DK099434
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK068306
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK115403
Pays : United States
Organisme : NIDDK NIH HHS
ID : R00 DK099434
Pays : United States

Informations de copyright

Copyright © 2019 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.

Références

Curr Biol. 2001 Oct 16;11(20):1586-90
pubmed: 11676918
Nat Genet. 2002 Mar;30(3):259-69
pubmed: 11919560
J Am Soc Nephrol. 2002 Sep;13(9):2384-98
pubmed: 12191984
Anat Embryol (Berl). 2002 Oct;205(5-6):431-40
pubmed: 12382146
Proc Natl Acad Sci U S A. 2003 Apr 29;100(9):5286-91
pubmed: 12672950
Dev Biol. 2004 Dec 15;276(2):403-15
pubmed: 15581874
Nat Cell Biol. 2005 May;7(5):517-24
pubmed: 15852003
Nature. 2006 Dec 14;444(7121):949-52
pubmed: 17122773
Hum Mol Genet. 2007 Dec 15;16(24):3188-96
pubmed: 17932118
J Cell Biol. 2007 Oct 22;179(2):321-30
pubmed: 17954613
J Cell Biol. 2008 Nov 3;183(3):377-84
pubmed: 18981227
PLoS One. 2009 Nov 26;4(11):e8054
pubmed: 19956655
N Engl J Med. 2011 Apr 21;364(16):1533-43
pubmed: 21506742
Nature. 2011 Jun 15;474(7351):337-42
pubmed: 21677750
Cell. 2012 Aug 3;150(3):533-48
pubmed: 22863007
J Cell Biol. 2012 Dec 24;199(7):1083-101
pubmed: 23253480
Genes Dev. 2013 Jan 15;27(2):163-8
pubmed: 23348840
Proc Natl Acad Sci U S A. 2013 Apr 9;110(15):5987-92
pubmed: 23530209
Biol Open. 2013 Apr 09;2(6):535-45
pubmed: 23789104
Nat Genet. 2013 Sep;45(9):1004-12
pubmed: 23892607
Nat Commun. 2013;4:2750
pubmed: 24231678
J Am Soc Nephrol. 2015 Jan;26(1):81-94
pubmed: 24904087
Nat Cell Biol. 2015 Mar;17(3):228-240
pubmed: 25686250
Anat Sci Int. 2017 Mar;92(2):207-214
pubmed: 26424481
Hum Mol Genet. 2017 Aug 1;26(15):2949-2960
pubmed: 28486600
PLoS Genet. 2017 Dec 15;13(12):e1007128
pubmed: 29244804
J Cell Physiol. 2018 Aug;233(8):6173-6195
pubmed: 29330844
Aspen Emphysema Conf. 1968;11:213-6
pubmed: 5751848
Eur J Biochem. 1997 Jan 15;243(1-2):527-36
pubmed: 9030781

Auteurs

Rannar Airik (R)

Division of Nephrology, Department of Pediatrics, University of Pittsburgh, Pittsburgh, Pennsylvania, USA; Department of Developmental Biology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.

Merlin Airik (M)

Division of Nephrology, Department of Pediatrics, University of Pittsburgh, Pittsburgh, Pennsylvania, USA. Electronic address: airikr@pitt.edu.

Markus Schueler (M)

Department of Nephrology and Hypertension, University Hospital of Erlangen, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany.

Carlton M Bates (CM)

Division of Nephrology, Department of Pediatrics, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.

Friedhelm Hildebrandt (F)

Division of Nephrology, Boston Children's Hospital, Boston, Massachusetts, USA. Electronic address: Friedhelm.Hildebrandt@childrens.harvard.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH